AJR Am J Roentgenol 2020 Oct 21
Borderline Resectable and Locally Advanced Pancreas Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Neoadjuvant Therapy Pathologic Response and Prediction of Survival.
Related Questions
How did the SWOG 1505 clinical trial influence your clinical practice?
New answer by Medical Oncologist at Mayo Clinic (September 10, 2023)
We typically use FOLFIRINOX as well and monitor with FDG PET, MRI, and CT. Metabolic response is associated with path response (not surprising) and also OS. The results from o...